AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33914595 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide plus ADT
Number of subjects: 1052
Study 33914595 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1052
Study 36726374 — intervention group
Group type: EXPERIMENTAL
Intervention: Most‐Liked Music (MLM)
Number of subjects: 0
Study 36726374 — intervention group
Group type: EXPERIMENTAL
Intervention: Least‐Liked Music (LLM)
Number of subjects: 0
Study 36726374 — intervention group
Group type: COMPARATOR
Intervention: Conditioned Pain Modulation (CPM)
Number of subjects: 0
Study 35025542 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) and interpersonal psychotherapy (IPT)
Number of subjects: 159
Study 32380950 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation-based gait training on a treadmill, 4 weeks, two times per week, with simulated slips and trips and cognitive dual tasks.
Number of subjects: 70
Study 32380950 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training under cognitive dual-task conditions without perturbations (Control group).
Number of subjects: 70
Study 32380950 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups assessed on clinical balance and gait assessments, and questionnaires on falls- and gait-efficacy.
Number of subjects: 70
Study 36112027 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning in postpartum haemorrhage and written course material in preeclampsia
Number of subjects: 45
Study 36112027 — intervention group
Group type: COMPARATOR
Intervention: E-learning in preeclampsia and written course material in postpartum haemorrhage
Number of subjects: 45
Study 34472114 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT therapist-led (CBTth)
Number of subjects: 457
Study 34472114 — intervention group
Group type: COMPARATOR
Intervention: CBT guided-self-help (CBTgsh)
Number of subjects: 457
Study 32157242 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Gy/SF (single fraction)
Number of subjects: 112
Study 32157242 — intervention group
Group type: COMPARATOR
Intervention: 20 Gy/5Fx (five fractions)
Number of subjects: 112
Study 35576548 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal opioid-sparing pain management protocol
Number of subjects: 90
Study 35576548 — intervention group
Group type: COMPARATOR
Intervention: Traditional opioid-containing pain management protocol
Number of subjects: 90
Study 35576548 — intervention group
Group type: COMPARATOR
Intervention: Traditional opioid-containing pain management protocol with additional local infiltration analgesia (LIA)
Number of subjects: 90
Study 33852248 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sarecycline (once-daily, weight-based dosing)
Number of subjects: 102
Study 33852248 — intervention group
Group type: COMPARATOR
Intervention: Control (multivitamin tablet)
Number of subjects: 102
Study 32852531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg, weeks 1 and 3)
Number of subjects: 29
Study 32852531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab (Ipilimumab 1 mg/kg, week 1 only)
Number of subjects: 29
Study 35685982 — intervention group
Group type: EXPERIMENTAL
Intervention: Allograft patch augmentation
Number of subjects: 60
Study 35685982 — intervention group
Group type: COMPARATOR
Intervention: Control group (arthroscopic rotator cuff repair)
Number of subjects: 60
Study 35685982 — intervention group
Group type: EXPERIMENTAL
Intervention: Allograft group
Number of subjects: 60
Study 35685982 — intervention group
Group type: COMPARATOR
Intervention: Control group (CC subgroup)
Number of subjects: 60
Study 35685982 — intervention group
Group type: EXPERIMENTAL
Intervention: Allograft group (CC subgroup)
Number of subjects: 60
Study 35685982 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Constant and ASES scores)
Number of subjects: 60
Study 34556670 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine (BBR)
Number of subjects: 15
Study 34556670 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33021891 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol (10-mm slabs with 5-mm overlap, 1-mm slices, synthetic 2D mammogram)
Number of subjects: 122
Study 33021891 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental protocol (6-mm slabs with 3-mm overlap, synthetic 2D mammogram)
Number of subjects: 122
Study 33021891 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental protocol (6-mm slabs with 3-mm overlap)
Number of subjects: 122
Study 36213912 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear-focused Self-compassion Therapy
Number of subjects: 160
Study 36213912 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 160
Study 33371726 — intervention group
Group type: EXPERIMENTAL
Intervention: Focusing on Maryam's flower during labor
Number of subjects: 124
Study 32102708 — intervention group
Group type: EXPERIMENTAL
Intervention: Giardia spp. detection
Number of subjects: 0
Study 32102708 — intervention group
Group type: EXPERIMENTAL
Intervention: Other enteric pathogens (Salmonella enterica, enterotoxigenic E. coli, Shigella spp.)
Number of subjects: 0
Study 35261279 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl
Number of subjects: 3408
Study 35261279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3408
Study 36330499 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant gemcitabine (LT-Gem group)
Number of subjects: 12
Study 36330499 — intervention group
Group type: COMPARATOR
Intervention: LT alone (LT alone group)
Number of subjects: 12
Study 32951999 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual sufentanil tablet system
Number of subjects: 64
Study 32951999 — intervention group
Group type: COMPARATOR
Intervention: Nurse-controlled continuous morphine infusion
Number of subjects: 64
Study 32700158 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 0
Study 32700158 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial Mayo score
Number of subjects: 0
Study 35583544 — intervention group
Group type: EXPERIMENTAL
Intervention: 0° lateral view
Number of subjects: 10
Study 35583544 — intervention group
Group type: EXPERIMENTAL
Intervention: -15° rollunder lateral view
Number of subjects: 10
Study 35583544 — intervention group
Group type: COMPARATOR
Intervention: Standard posteroanterior view
Number of subjects: 10
Study 34768614 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS + PNfS
Number of subjects: 14
Study 34768614 — intervention group
Group type: COMPARATOR
Intervention: SCS only
Number of subjects: 14
Study 35443302 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Improvement Program for Rural Compulsory Education Students
Number of subjects: 1550969
Study 34536693 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft-soled sandals
Number of subjects: 47
Study 34536693 — intervention group
Group type: COMPARATOR
Intervention: Hard-soled sandals
Number of subjects: 47
Study 34536693 — intervention group
Group type: COMPARATOR
Intervention: Soft-soled runners
Number of subjects: 47
Study 34536693 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard-soled runners
Number of subjects: 47
Study 34536693 — intervention group
Group type: COMPARATOR
Intervention: Soft-soled boots
Number of subjects: 47
Study 34536693 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard-soled boots
Number of subjects: 47
Study 36405599 — intervention group
Group type: EXPERIMENTAL
Intervention: Yijinjing combined with elastic band exercise (5 times a week for 6 months)
Number of subjects: 47
Study 36405599 — intervention group
Group type: EXPERIMENTAL
Intervention: Yijinjing combined with elastic band exercise
Number of subjects: 47
Study 36405599 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained original lifestyle)
Number of subjects: 47
Study 36405599 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 32842248 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine balloon tamponade
Number of subjects: 161
Study 32842248 — intervention group
Group type: COMPARATOR
Intervention: Gauze packing
Number of subjects: 161
Study 32993441 — intervention group
Group type: EXPERIMENTAL
Intervention: Values comprising 'Self-Enhancement' and 'Openness to Change'
Number of subjects: 0
Study 32993441 — intervention group
Group type: COMPARATOR
Intervention: Values comprising 'Self-Transcendence' and 'Conservation'
Number of subjects: 0
Study 32993441 — intervention group
Group type: EXPERIMENTAL
Intervention: Compulsive buyers
Number of subjects: 0
Study 32993441 — intervention group
Group type: EXPERIMENTAL
Intervention: Values emphasizing importance of communal goals
Number of subjects: 0
Study 36166094 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed valgus angle distal femur resection (5-degree valgus correction)
Number of subjects: 49
Study 36166094 — intervention group
Group type: COMPARATOR
Intervention: Variable valgus angle distal femur resection (individualized valgus correction angle)
Number of subjects: 49
Study 36166094 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (fixed and variable angle)
Number of subjects: 49
Study 32886131 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological ischemic training (PIT)
Number of subjects: 165
Study 32886131 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug treatment (Control)
Number of subjects: 165
Study 32594760 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoactive intestinal polypeptide (VIP) infusion
Number of subjects: 12
Study 32594760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 34088532 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician guidance (PG)
Number of subjects: 32
Study 34088532 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 32
Study 32907777 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide (240mg/d)
Number of subjects: 1207
Study 32907777 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinsing and gargling mouthwash
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Rinsing duration
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Gargling duration
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Total duration of mouthwash use
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of mouthwash use by group
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash duration comparison by gender
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume of mouthwash used
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilution of mouthwash
Number of subjects: 200
Study 32994261 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison to randomized trial
Number of subjects: 200
Study 36181063 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 0
Study 33852571 — intervention group
Group type: EXPERIMENTAL
Intervention: EPIC tool
Number of subjects: 1092
Study 33852571 — intervention group
Group type: EXPERIMENTAL
Intervention: OLS models
Number of subjects: 1092
Study 33852571 — intervention group
Group type: EXPERIMENTAL
Intervention: Best model fit
Number of subjects: 1092
Study 32132224 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 215
Study 35216603 — intervention group
Group type: EXPERIMENTAL
Intervention: High robotic assistance group
Number of subjects: 30
Study 35216603 — intervention group
Group type: EXPERIMENTAL
Intervention: Low robotic assistance group
Number of subjects: 30
Study 32144013 — intervention group
Group type: EXPERIMENTAL
Intervention: Open aortic repair (OAR)
Number of subjects: 702
Study 32144013 — intervention group
Group type: EXPERIMENTAL
Intervention: OAR-only practice
Number of subjects: 702
Study 36286675 — intervention group
Group type: EXPERIMENTAL
Intervention: Remaxol (400 ml/day)
Number of subjects: 317
Study 36286675 — intervention group
Group type: COMPARATOR
Intervention: Heptral (800 mg/day)
Number of subjects: 317
Study 32915426 — intervention group
Group type: EXPERIMENTAL
Intervention: Dingkun Pill (7 g daily for 21 days, followed by 7 drug-free days)
Number of subjects: 117
Study 32915426 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane‐35 (1 tablet daily for 21 days, followed by 7 drug-free days)
Number of subjects: 117
Study 32915426 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (Dingkun Pill and Diane‐35)
Number of subjects: 117
Study 32915426 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 117
Study 35829672 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimekizumab 160 mg every 4 weeks
Number of subjects: 303
Study 33410228 — intervention group
Group type: EXPERIMENTAL
Intervention: ESWT plus low-dye KT
Number of subjects: 45
Study 33410228 — intervention group
Group type: COMPARATOR
Intervention: ESWT plus Sham-taping
Number of subjects: 45
Study 33410228 — intervention group
Group type: COMPARATOR
Intervention: ESWT only
Number of subjects: 45
Study 32600358 — intervention group
Group type: EXPERIMENTAL
Intervention: SPP (12‐15 mmHg) + deep‐NMB (post‐tetanic count of 1‐2)
Number of subjects: 648
Study 32600358 — intervention group
Group type: EXPERIMENTAL
Intervention: LPP (7‐10 mmHg) + deep‐NMB
Number of subjects: 648
Study 32600358 — intervention group
Group type: EXPERIMENTAL
Intervention: SPP + moderate‐NMB (train‐of‐four of 1‐2)
Number of subjects: 648
Study 32600358 — intervention group
Group type: EXPERIMENTAL
Intervention: LPP + moderate‐NMB
Number of subjects: 648
Study 32600358 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 648
Study 35176639 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exercise intervention (5 °C)
Number of subjects: 21
Study 35176639 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral exercise intervention (15 °C)
Number of subjects: 21
Study 35176639 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 21
Study 33314392 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly established review criteria for hematology analyzers
Number of subjects: 1003
Study 33314392 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation of newly established criteria
Number of subjects: 1003
Study 33314392 — intervention group
Group type: COMPARATOR
Intervention: ICGH criteria (control)
Number of subjects: 1003
Study 36545533 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation group (PBMG)
Number of subjects: 34
Study 36545533 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 34
Study 33853639 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 384
Study 33853639 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 384
Study 34625954 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 1638
Study 34625954 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1638
Study 33169699 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min aerobic exercise at moderate intensity
Number of subjects: 49
Study 33169699 — intervention group
Group type: COMPARATOR
Intervention: Relaxation (control group)
Number of subjects: 49
Study 32418547 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee with milk and sugar
Number of subjects: 21
Study 32418547 — intervention group
Group type: EXPERIMENTAL
Intervention: Black coffee
Number of subjects: 21
Study 32418547 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 21
Study 35005040 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning-centered play intervention, implemented in twelve 45-minute sessions, twice a week for six weeks.
Number of subjects: 120
Study 35005040 — intervention group
Group type: COMPARATOR
Intervention: Usual trend of the center's plays and programs (Control group).
Number of subjects: 120
Study 32680943 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted average accelerations
Number of subjects: 63926
Study 32680943 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability for fraction of accelerations >425 milligravities
Number of subjects: 63926
Study 36011781 — intervention group
Group type: EXPERIMENTAL
Intervention: Hungarian version of SCREENIVF
Number of subjects: 60
Study 36011781 — intervention group
Group type: COMPARATOR
Intervention: FertiQoL
Number of subjects: 60
Study 33438516 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (HS; 250 mEq sodium/day)
Number of subjects: 9
Study 33438516 — intervention group
Group type: COMPARATOR
Intervention: Low-salt diet (LS; 50 mEq sodium/day)
Number of subjects: 9
Study 32646743 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery calcium scoring
Number of subjects: 1000
Study 32646743 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferral of statin therapy
Number of subjects: 1000
Study 32646743 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery calcium scoring in women 50 years and older
Number of subjects: 1000
Study 33939143 — intervention group
Group type: EXPERIMENTAL
Intervention: Hunger-based feeding
Number of subjects: 110
Study 33939143 — intervention group
Group type: COMPARATOR
Intervention: Conventional feeding
Number of subjects: 110
Study 33236676 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug therapy problems (adverse drug reactions)
Number of subjects: 71
Study 33236676 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrointestinal problems
Number of subjects: 71
Study 33236676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular diseases
Number of subjects: 71
Study 33236676 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological health score
Number of subjects: 71
Study 33236676 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemia presence
Number of subjects: 71
Study 33236676 — intervention group
Group type: EXPERIMENTAL
Intervention: Coverage
Number of subjects: 71
Study 33236676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular problems
Number of subjects: 71
Study 32898792 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch maintenance chemotherapy (pemetrexed 500 mg/m2 d1, 22 for non-squamous cell carcinoma; gemcitabine 1,150 mg/m2 d1, 8, 22 for squamous cell carcinoma)
Number of subjects: 328
Study 32898792 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 328
Study 32898792 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch maintenance chemotherapy
Number of subjects: 328
Study 35953245 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg daily
Number of subjects: 20
Study 35953245 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin two times per day
Number of subjects: 20
Study 35953245 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 20
Study 35953245 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 20
Study 33196083 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual cues on packaging (salient labeled stripes)
Number of subjects: 927
Study 33196083 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no visual cues)
Number of subjects: 927
Study 32152868 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Insomnia (BBT-I)
Number of subjects: 25
Study 32152868 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring control
Number of subjects: 25
Study 35060404 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session Acceptance and Commitment Therapy intervention (<3 hours)
Number of subjects: 15
Study 33483850 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-arousal group (participants rated willingness to have sex with a condom if their own arousal decreased from 100 to 10%)
Number of subjects: 379
Study 33483850 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner-arousal group (participants rated willingness to have sex with a condom if their partner's arousal decreased from 100 to 10%)
Number of subjects: 379
Study 33483850 — intervention group
Group type: EXPERIMENTAL
Intervention: Men (vs. women) in the most desirable partner condition
Number of subjects: 379
Study 33483850 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher arousal discounting
Number of subjects: 379
Study 34392376 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 0
Study 34392376 — intervention group
Group type: COMPARATOR
Intervention: Non-smokers
Number of subjects: 0
Study 34392376 — intervention group
Group type: COMPARATOR
Intervention: BMI categories
Number of subjects: 0
Study 34392376 — intervention group
Group type: COMPARATOR
Intervention: Smoking status
Number of subjects: 0
Study 34392376 — intervention group
Group type: COMPARATOR
Intervention: BMI
Number of subjects: 0
Study 34313874 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening group
Number of subjects: 80149
Study 34313874 — intervention group
Group type: EXPERIMENTAL
Intervention: T1c tumor diagnosis rates
Number of subjects: 80149
Study 34313874 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80149
Study 32554365 — intervention group
Group type: EXPERIMENTAL
Intervention: Periarticular injection of 20 mL 0.5% bupivacaine HCl (100 mg) after implantation
Number of subjects: 90
Study 32554365 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined periarticular injection of 20 mL 0.5% bupivacaine HCl (100 mg) and incisional injection of 10 mL 0.5% bupivacaine HCl (50 mg)
Number of subjects: 90
Study 32554365 — intervention group
Group type: COMPARATOR
Intervention: No injection (control group)
Number of subjects: 90
Study 35285906 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.50 g · kg‐1 · d‐1 protein plus multinutrient beverage (NUT)
Number of subjects: 20
Study 35285906 — intervention group
Group type: COMPARATOR
Intervention: 0.900 g · kg‐1 · d‐1 protein plus placebo (PLA)
Number of subjects: 20
Study 35285906 — intervention group
Group type: EXPERIMENTAL
Intervention: NUT
Number of subjects: 20
Study 35285906 — intervention group
Group type: COMPARATOR
Intervention: PLA
Number of subjects: 20
Study 35717385 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief counselling strategies for smoking cessation and risky alcohol consumption
Number of subjects: 0
Study 35717385 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0